SELECTIVE HISTAMINE H3 ANTAGONIST ACID ADDITION SALTS AND PROCESS FOR THE PREPARATION THEREOF

The present invention relates to physically and chemically stable salts of the selective histamine preceptor antagonist compound of l-[4-(4-{3-[(2R)-2-methyl-pyrrolidin-l-yl]-propoxy}-phenoxy)- piperidin-l-yl]-ethanone of formula (1) and/or polymorphs thereof and/or hydrates/solvates thereof, the pr...

Full description

Saved in:
Bibliographic Details
Main Authors MEISZTERICS ANIKO, SEBOK FERENC, DEMETER ADAM
Format Patent
LanguageChinese
English
Published 07.01.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to physically and chemically stable salts of the selective histamine preceptor antagonist compound of l-[4-(4-{3-[(2R)-2-methyl-pyrrolidin-l-yl]-propoxy}-phenoxy)- piperidin-l-yl]-ethanone of formula (1) and/or polymorphs thereof and/or hydrates/solvates thereof, the process for the preparation thereof, pharmaceutical compositions comprising them, and for use in the treatment and/or prevention of conditions requiring the modulation of histamine H3 receptors (e.g. Alzheimer's disease, obesity, schizophrenia, miochardial ischaemia, migraine, autism spectrum disorder). 本发明涉及式(1)的1-[4-(4-{3-[(2R)-2-甲基-吡咯烷-1-基]-丙氧基}-苯氧基)-哌啶-1-基]-乙酮的选择性组胺H3受体拮抗剂化合物的物理和化学稳定的盐,和/或其多晶型物和/或其水合物/溶剂化物、其制备方法、包含它们的药物组合物以及用于治疗和/或预防需要调节组胺H3受体的病症(例如阿尔茨海默病、肥胖症、精神分裂症、心肌缺血、偏头痛、孤独症谱系障碍)。
Bibliography:Application Number: CN202080040296